Oncology & Cancer

Study sheds light on how ovarian cancer spreads

With 20,000 diagnoses each year, ovarian cancer is the ninth most common cancer and fifth leading cause of cancer death among women in the United States. So many women die from ovarian cancer because it often goes undetected ...

Oncology & Cancer

New study illuminates why cancers caused by BRCA mutations recur

Researchers at the University of Pennsylvania's Basser Center for BRCA at the Abramson Cancer Center have discovered factors that may make breast and ovarian cancers associated with BRCA1/2 gene mutations more likely to recur.

Oncology & Cancer

New ovarian cancer drug Lynparza one step closer

Ovarian cancer patients throughout Europe and the United States could soon be treated with a new drug discovered through pioneering research at the University of Sheffield funded by Yorkshire Cancer Research.

Oncology & Cancer

Targeting stem-like cells could prevent ovarian cancer recurrence

Ovarian cancer is not the most common form of cancer, but it's among the deadliest. That's because about 70 percent of cases recur. A new study by researchers at the University of Pittsburgh, UPMC Hillman Cancer Center, Magee-Womens ...

page 7 from 40